Bottom line
How has FDAFX performed?
As of May 31, 2026, FDAFX returned +7.7% over the past year, +3.2% a year over five years, +6.2% a year over ten years. That means $10,000 invested ten years earlier would have grown to about $18,300. Its five-year return beat 1% of target-date funds we track. Its best quarter was +12.3% and its worst −12.4%.
Updated May 31, 2026
FDAFX annual returns by year
| Year | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FDAFX | +14.3% | +6.8% | +12.1% | −16.3% | +8.3% | +13.0% | +18.4% | −5.1% | +15.0% | +6.9% | −0.9% |
Source: Fund prospectus bar chart (risk/return summary)
Growth of $10,000 in FDAFX
$10,000 invested at the start of 2015 would have been worth about $19,200 by the end of 2025, based on the fund's reported calendar-year returns.
| Year | Return | Value of $10,000 |
|---|---|---|
| 2025 | +14.3% | $19,203 |
| 2024 | +6.8% | $16,804 |
| 2023 | +12.1% | $15,734 |
| 2022 | −16.3% | $14,037 |
| 2021 | +8.3% | $16,770 |
| 2020 | +13.0% | $15,481 |
| 2019 | +18.4% | $13,695 |
| 2018 | −5.1% | $11,567 |
| 2017 | +15.0% | $12,182 |
| 2016 | +6.9% | $10,596 |
| 2015 | −0.9% | $9,909 |
Trailing returns vs benchmark and category
| 1 yr | 5 yr | 10 yr | Since inception | |
|---|---|---|---|---|
| FDAFX | +7.7% | +3.2% | +6.2% | — |
| Target-Date median | +15.7% | +8.2% | +8.9% | — |
Source: Prospectus as of May 31, 2026; category medians computed by MutualFund.com
Recent monthly returns
For the three months ending Jun 30, 2026, FDAFX returned +4.60%, +1.65%, +0.55% (oldest to newest), per SEC Form N-PORT.
Past performance does not guarantee future results. Returns assume reinvested distributions and are net of fund expenses, as reported by the fund.